01276.HK
Jiangsu Hengrui Pharmaceuticals Co.,Ltd
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 46.50
+0.74%Margins
Gross margin
85.0%
EBITDA margin
26.5%
EBIT margin
24.3%
Net margin
24.8%
FCF margin
18.0%
11.7%
Return on equity
10.6%
Return on assets
11.3%
Return on invested capital
0.43x
Asset turnover
HKD 10.0B
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026